Science Explorer Back to mapMap
Discussion
Company · Tainan City · Taiwan

ScinoPharm Taiwan (Taiwan)

Research works
23
▲ 94% vs 2018-21
Citations
736
32.7 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
6%
world 40%
International
8%
world 18%

Not ranked overall: ScinoPharm Taiwan (Taiwan) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ScinoPharm Taiwan (Taiwan) work in?

In all years, 61% of research at ScinoPharm Taiwan (Taiwan) is in Physical Sciences, 20% in Life Sciences. Its largest fields are Chemistry (35%), Biochemistry, Genetics and Molecular Biology (18%), Medicine (18%). It does 1.4× the world's share of Physical Sciences.

Physical Sciences: 14 fractional works · 61.0% of its workChemistry: 8 fractional works · 34.6% of its workOrganic Chemistry: 6 fractional works · 28.2% of its workInorganic Chemistry: 1 fractional works · 4.0% of its workSpectroscopy: 0 fractional works · 1.7% of its workAnalytical Chemistry: 0 fractional works · 0.8% of its workEngineering: 3 fractional works · 11.3% of its workElectrical and Electronic Engineering: 2 fractional works · 8.9% of its workMechanical Engineering: 0 fractional works · 1.5% of its workMechanics of Materials: 0 fractional works · 0.5% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workMaterials Science: 2 fractional works · 7.3% of its workPolymers and Plastics: 1 fractional works · 3.7% of its workMaterials Chemistry: 1 fractional works · 2.6% of its workBiomaterials: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 1 fractional works · 3.3% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.5% of its workPollution: 0 fractional works · 1.5% of its workEcology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysics and Astronomy: 1 fractional works · 2.3% of its workCondensed Matter Physics: 1 fractional works · 2.3% of its workEnergy: 0 fractional works · 2.2% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 2.2% of its workLife Sciences: 5 fractional works · 20.4% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 18.1% of its workMolecular Biology: 3 fractional works · 15.4% of its workCancer Research: 1 fractional works · 2.4% of its workBiotechnology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 1.5% of its workPlant Science: 0 fractional works · 1.5% of its workImmunology and Microbiology: 0 fractional works · 0.8% of its workImmunology: 0 fractional works · 0.8% of its workHealth Sciences: 4 fractional works · 18.6% of its workMedicine: 4 fractional works · 17.8% of its workInfectious Diseases: 1 fractional works · 4.0% of its workOncology: 1 fractional works · 3.5% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 3.0% of its workPharmacology: 0 fractional works · 1.9% of its workEpidemiology: 0 fractional works · 1.5% of its workGenetics: 0 fractional works · 1.5% of its workBiochemistry: 0 fractional works · 0.8% of its workComplementary and alternative medicine: 0 fractional works · 0.8% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.5% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.8% of its workNutrition and Dietetics: 0 fractional works · 0.8% of its workALL ITS WORKScinoPharm Taiwan(Taiwan)23fractional works, all years
Life Sciences20%Physical Sciences61%Health Sciences19%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 11 fields, with their numbers
    1. Chemistry834.6%
    2. Engineering311.3%
    3. Materials Science27.3%
    4. Environmental Science13.3%
    5. Physics and Astronomy12.3%
    6. Energy02.2%
    1. Biochemistry, Genetics and Molecular Biology418.1%
    2. Agricultural and Biological Sciences01.5%
    3. Immunology and Microbiology00.8%
    1. Medicine417.8%
    2. Nursing00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at ScinoPharm Taiwan (Taiwan)?

Ranked on the quality score, Julian P. Henschke lead among researchers whose main affiliation is ScinoPharm Taiwan (Taiwan).

  1. 1 Julian P. Henschke Taiwan · #3,297,765 worldwide 921 citations · 40 works
All ranked researchers at ScinoPharm Taiwan (Taiwan)

What are the most cited papers from ScinoPharm Taiwan (Taiwan)?

The most cited paper from ScinoPharm Taiwan (Taiwan) is "Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition" (Muh‐Hwa Yang, Dennis Shin‐Shian Hsu, Hsei-Wei Wang et al., 2010), with 636 citations. Next come "Studies of glycolysis of poly(ethylene terephthalate) recycled from postconsumer soft‐drink bottles. I. Influences of glycolysis conditions" (129) and "K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression" (126).

Most cited papers
#PaperReleasedCitations
1 Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition Muh‐Hwa Yang, Dennis Shin‐Shian Hsu, Hsei-Wei Wang et al. · Nature Cell Biology 5 Sep 2010 636
2 Studies of glycolysis of poly(ethylene terephthalate) recycled from postconsumer soft‐drink bottles. I. Influences of glycolysis conditions Cheng‐Ho Chen, Cheng‐Ho Chen, Chuh‐Yean Chen et al. · Journal of Applied Polymer Science 2 Mar 2001 129
3 K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression Han‐Tsang Wu, Yi-Chih Kuo, Jung‐Jyh Hung et al. · Nature Communications Open access 9 Dec 2016 126
4 Efficient organic DSSC sensitizers bearing an electron-deficient pyrimidine as an effective π-spacer Li‐Yen Lin, Chih‐Hung Tsai, Ken‐Tsung Wong et al. · Journal of Materials Chemistry 2011 110
5 Antioxidant Activity of Methanol Extract of the Lotus Leaf (Nelumbo nucifera Gertn.) Ming‐Jiuan Wu, Lisu Wang, Ching‐Yi Weng et al. · The American Journal of Chinese Medicine 2003 83
All 48 most cited papers, with filters and sorting

Which keywords describe research at ScinoPharm Taiwan (Taiwan)?

By fractional works in all years, weighted toward what it does more of than the world: Transition Metal Catalysis, Enantioselective Reactions, Organocatalysis, C-C Bond Formation, Asymmetric Synthesis, Chiral Catalysts, Spirooxindoles and Anti-inflammatory.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Transition Metal Catalysis2▲ 75×3 topics
  2. Enantioselective Reactions2▲ 110×2 topics
  3. Organocatalysis2▲ 123×3 topics
  4. Asymmetric Synthesis2▲ 54×4 topics
  5. C-C Bond Formation2▲ 85×2 topics
  6. Chiral Catalysts1▲ 124×1 topic
  7. Spirooxindoles1▲ 124×1 topic
  8. Anti-inflammatory1▲ 21×5 topics
  9. Antioxidant1▲ 8.7×5 topics
  10. Asymmetric Catalysis1▲ 85×2 topics
  11. Enantioselective Synthesis1▲ 33×3 topics
  12. Glycosidase Inhibitors1▲ 101×1 topic
  13. Metal-Catalyzed Reactions1▲ 58×2 topics
  14. Nanoparticles1▲ 4.0×6 topics
  15. Oligosaccharide Synthesis1▲ 101×1 topic
  16. Recycling1▲ 21×3 topics
  17. Cancer1▲ 3.6×6 topics
  18. Chiral Ligands1▲ 90×2 topics
  19. Transition Metal Complexes1▲ 42×2 topics

Which research topics does ScinoPharm Taiwan (Taiwan) publish most on?

By volume in 2022-now: Mass Spectrometry Techniques and Applications, RNA and protein synthesis mechanisms and Chemical Synthesis and Analysis.

  1. 1 Mass Spectrometry Techniques and Applications Spectroscopy 0 works
  2. 2 RNA and protein synthesis mechanisms Molecular Biology 0 works
  3. 3 Chemical Synthesis and Analysis Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available5.9%not open94.1%

World: 40% of research is openly available.

with international co-authors7.6%domestic only92.4%

World: 18% is written across borders.

How has ScinoPharm Taiwan (Taiwan)'s research output changed?

Output in 2022-2025 was 94% higher than in 2018-2021.

2005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ScinoPharm Taiwan (Taiwan) as a percentage of every work published that year, 0.0000038% in 2019.

0.000050%0.00010%0.00015%ScinoPharm Taiwan (Taiwan)0.0000060% in 202420102020

Fractional works of ScinoPharm Taiwan (Taiwan) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Tainan City

All research institutions in Tainan City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ScinoPharm Taiwan (Taiwan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.